Pramlintide Research Guide

Full name: Pramlintide (Symlin)

An FDA-approved synthetic analog of the hormone amylin, used alongside insulin in diabetes. It slows gastric emptying and promotes satiety, and is of interest in biohacker circles for appetite control and glucose management.

How Pramlintide Works

Mimics amylin by activating amylin receptors, which slows gastric emptying, suppresses inappropriate glucagon secretion after meals, and increases satiety - complementing insulin's effects.

Dosing Protocol

• Typical dose: 15-120 mcg before meals
• Frequency: Before major meals
• Duration: Ongoing
• Route: Subcutaneous injection

Reported Benefits

• Appetite suppression and satiety
• Slows gastric emptying
• Improves post-meal glucose control
• Modest weight loss

Potential Side Effects

• Nausea
• Hypoglycemia (with insulin)
• Reduced appetite
• Injection site reactions

Research Citations

1. Pramlintide and weight in insulin-treated patients (2016) - Improved glycemic control and produced modest weight loss versus insulin alone.

Related Weight Management Compounds

• AOD-9604 - Full Profile
• Semaglutide - Full Profile
• Tirzepatide - Full Profile
• Retatrutide - Full Profile
• Tesofensine - Full Profile
• CagriSema - Full Profile

View full Pramlintide profile with 3D molecule viewer →